Malarone and Nosebleed - from FDA reports


Summary

Nosebleed is found among people who take Malarone, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Ivermectin, and have Plasmodium falciparum infection. This review analyzes which people have Nosebleed with Malarone. It is created by eHealthMe based on reports of 2,284 people who have side effects when taking Malarone from FDA , and is updated regularly.

What to expect?

If you take Malarone and have Nosebleed, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Malarone and have Nosebleed

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 24, 2017

2,284 people reported to have side effects when taking Malarone.
Among them, 17 people (0.74%) have Nosebleed


Number of reports submitted per year:

Could Malarone cause Nosebleed?

Time on Malarone when people have Nosebleed *:

  • < 1 month: 93.33 %
  • 1 - 6 months: 6.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Nosebleed when taking Malarone *:

  • female: 70.59 %
  • male: 29.41 %

Age of people who have Nosebleed when taking Malarone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.67 %
  • 30-39: 26.67 %
  • 40-49: 6.67 %
  • 50-59: 13.33 %
  • 60+: 46.67 %

Top conditions involved for these people *:

  • Plasmodium Falciparum Infection (4 people, 23.53%)
  • Atrial Fibrillation/flutter (1 person, 5.88%)

Top co-used drugs for these people *:

  • Ivermectin (4 people, 23.53%)
  • Renagel (3 people, 17.65%)
  • Nexium (3 people, 17.65%)
  • Gaviscon (3 people, 17.65%)
  • Ativan (1 person, 5.88%)

Top other side effects for these people *:

  • Nausea And Vomiting (6 people, 35.29%)
  • Nausea (6 people, 35.29%)
  • Pancytopenia (5 people, 29.41%)
  • Head Injury (4 people, 23.53%)
  • Abdominal Pain (4 people, 23.53%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Nosebleed when taking Malarone?

Expand the study to include all drugs with the same ingredients

Nosebleed and drugs with ingredients of atovaquone; proguanil hydrochloride.

Expand the study to include reports from both FDA and eHealthMe

Nosebleed and Malarone from FDA and eHealthMe reports

Malarone

Malarone has active ingredients of atovaquone; proguanil hydrochloride. It is often used in malaria. (latest outcomes from Malarone 2,697 users)

Nosebleed

Nosebleed (bleeding from nose) has been reported by people with atrial fibrillation/flutter, stroke, high blood pressure, thrombosis, rheumatoid arthritis (latest reports from 45,748 Nosebleed patients).

Browse all side effects of Malarone

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Nosebleed

Nosebleed

Could your condition cause Nosebleed

Nosebleed

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Malarone and have Nosebleed.

Questions to the study

More questions >

User posts to the study

More posts >